Ganciclovir ophthalmic Pregnancy and Breastfeeding Warnings
Ganciclovir ophthalmic is also known as: Vitrasert, Zirgan
Ganciclovir ophthalmic Pregnancy Warnings
Ganciclovir ophthalmic implant and ganciclovir ophthalmic gel have been assigned to pregnancy category C by the FDA. Reproduction studies in rabbits and mice have shown ganciclovir to be embryotoxic and teratogenic following intravenous administration of relatively high doses. There are no controlled data in human pregnancy. Ganciclovir ophthalmic implant and ganciclovir ophthalmic gel are only recommended for use during pregnancy when benefit outweighs risk.
Ganciclovir ophthalmic Breastfeeding Warnings
There are no data on the excretion of ganciclovir into human milk. The manufacturer of ganciclovir ophthalmic implant recommends that due to the potential for serious adverse reactions in nursing infants, a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. The manufacturer of ganciclovir ophthalmic gel recommends that caution be used when administering ganciclovir ophthalmic gel to nursing women.
See Also...
- ganciclovir gel Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
